Cationic micelle based vaccine induced potent humoral immune response through enhancing antigen uptake and formation of germinal center

•The micelle facilitated OVA antigen uptake by dendritic cells both in vitro and in vivo.•Themicelle-formulated OVA vaccine promoted anti-OVA antibodies production.•Themicelle-formulated OVA vaccine improved both Th-1 and Th-2 immune response.

Nanoparticles have been proven to be an effective vaccine delivery system that can boost immune responses to subunit vaccines. Herein, we developed and characterized a cationic polymeric polyethylene glycol2000-poly ϵ-caprolactone2000-polyethylenimine2000 (mPEG2000-PCL2000-g-PEI2000) micelle as a potent vaccine delivery system to boost the immune response in vivo. The micelles that we developed exhibited great antigen-loading capability and minimal cytotoxicity in vitro. Meanwhile, micelles facilitated OVA antigen uptake by dendritic cells both in vitro and in vivo. More importantly, a micelle-formulated OVA vaccine could significantly promote anti-OVA antibody production by 190-fold and potently enhance T cell proliferation and the secretion of IL-5 and IFN-γ. We attributed these effects to its ability to promote antigen uptake, antigen deposition, and germinal center formation. In conclusion, the mPEG2000-PCL2000-PEI2000 micelle that we developed has potential as potent vaccine delivery system to induce Th2 immune response.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide